Lv1
46 积分 2021-08-08 加入
Target identification and assessment in the era of AI
1天前
已完结
Commentary on Endotypes in Chronic Spontaneous Urticaria: Where we go wrong
1天前
已完结
Targeting Bruton's tyrosine kinase in B cell malignancies
4天前
已完结
Therapeutic implications of baricitinib in mouse model of vitiligo
7天前
已完结
A Hairless Mouse Model for Vitiligo: Enhancing Preclinical Therapeutic Evaluation
7天前
已完结
The skin delivery of tofacitinib citrate using transethosomes and hybridized ethosomes/nanostructured lipid carriers for vitiligo therapy: Dermatopharmacokinetics and in vivo assays
7天前
已完结
Concurrent Inhibition of Kit- and FcϵRI-Mediated Signaling: Coordinated Suppression of Mast Cell Activation
8天前
已完结
Remission of food allergy by the Janus kinase inhibitor ruxolitinib in mice
9天前
已完结
Rilzabrutinib for persistent or chronic immune thrombocytopenia (ITP): a Bruton tyrosine kinase inhibitor that can target multiple pathophysiological pathways
11天前
已完结
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase
11天前
已完结
皖公网安备34019202002308
